Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
October 24, 2021
Tickers
AGEN
AVIR
BMY
DWAC
Tags
DWAC
SHIB
RHHBY
From
Motley Fool
2 High-Yielding Stocks You Can Buy and Hold for Years
October 23, 2021
Tickers
CPB
GILD
Tags
GILD
CPB
Market News
From
Motley Fool
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
October 23, 2021
Tickers
GILD
MRK
Tags
Market News
MRK
GILD
From
Motley Fool
3 Under-the-Radar COVID Stocks
October 20, 2021
Tickers
BLUE
BMS
CYRX
GILD
Tags
TTD
MRNA
SQ
From
Motley Fool
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
Tickers
ALPMF
BLUE
CRSP
EDIT
Tags
RGEN
Market News
ALPMF
From
Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
Tickers
ALLO
ALPMF
BIIB
BLUE
Tags
MRNA
XBI
BIIB
From
Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
Tickers
ABBV
BMY
GILD
JNJ
Tags
ABBV
MRK
RHHBY
From
Benzinga
CRSP Stock: The Cancer Study News Sending Crispr Therapeutics Lower Today
October 13, 2021
Tickers
CRSP
GILD
NVS
PLUG
Tags
Today's Market
GILD
WTRH
From
InvestorPlace
Why CRISPR Therapeutics Stock Is Sinking Today
October 13, 2021
Tickers
CRSP
GILD
NVS
Tags
Market News
CRSP
NVS
From
Motley Fool
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means
October 12, 2021
Tickers
AVIR
GILD
MRK
PFE
Tags
MRK
Biotech
General
From
Benzinga
Moderna Stock Looks Fully Valued Here, But It Has a Great Future
October 08, 2021
Tickers
AZN
BNTX
GILD
GSK
Tags
MRK
GSK
BNTX
From
InvestorPlace
Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?
October 06, 2021
Tickers
GILD
MRK
PFE
Tags
GILD
MRK
PFE
From
Motley Fool
Why Gilead Sciences Investors Shouldn't Give Up on Remdesivir Just Yet
October 06, 2021
Tickers
GILD
MRNA
PFE
Tags
GILD
MRNA
PFE
From
Motley Fool
Could Pfizer's COVID Pill Be Better Than Merck's?
October 06, 2021
Tickers
GILD
MRK
PFE
Tags
GILD
Market News
PFE
From
Motley Fool
NanoViricides Leaps Forward in its Quest to Defeat COVID-19
October 05, 2021
Tickers
GILD
JNJ
MRNA
NNVC
Tags
Benzinga
Partner Content
General
From
Benzinga
Tesla and Merck Give Investors Some Hope
October 04, 2021
Tickers
GILD
GSK
JNJ
MRK
Tags
Health Care
Treasuries
JNJ
From
Benzinga
Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease
October 04, 2021
Tickers
GILD
GLPG
GLPGF
Tags
GLPGF
General
Benzinga
From
Benzinga
This Healthcare Company Is Using AI to Develop Drugs
October 03, 2021
Tickers
BMY
GILD
SDGR
SNY
Tags
SNY
Market News
ZLAB
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Tickers
ANIP
AVDL
BHC
CALT
Tags
SNY
Penny Stocks
AVDL
From
Benzinga
Why a pill you take at home could change the direction of the pandemic
October 01, 2021
Tickers
ADMP
AVIR
GILD
GSK
Tags
ADMP
GSK
MRK
From
MarketWatch
Gilead's Kite Files US Application To Expand Use Of Yescarta In Second-Line Setting
October 01, 2021
Tickers
GILD
Tags
Briefs
Market News
Biotech
From
Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
Tickers
ADMA
ADVM
AGRX
AGTC
Tags
IPOs
ADMA
AGRX
From
Benzinga
3 Top Dividend Stocks Yielding More Than 4%
September 30, 2021
Tickers
BNS
GILD
VZ
Tags
Market News
BNS
VZ
From
Motley Fool
Merck's COVID-19 Antiviral Pill Effective Against Variants, Lab Studies Show
September 29, 2021
Tickers
GILD
MRK
PFE
Tags
PFE
General
News
From
Benzinga
GSK, Pfizer Backed Long-Acting HIV Med Under FDA Priority Review As Preventative Option
September 28, 2021
Tickers
GILD
GSK
PFE
Tags
Trading Ideas
News
PFE
From
Benzinga
Gilead Scores Fifth Approval For Trodelvy In Triple-Negative Breast Cancer, This Time In Canada
September 28, 2021
Tickers
GILD
Tags
Briefs
Market News
Biotech
From
Benzinga
Pfizer Begins Late-Stage Study To Test Effectiveness Of Oral Drug Against COVID-19 In Those Exposed To The Virus
September 28, 2021
Tickers
GILD
MRK
PFE
Tags
SARS/CoV/2
GILD
Benzinga
From
Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
September 27, 2021
Tickers
BNTX
GILD
LLY
NVAX
Tags
GILD
LLY
NVAX
From
Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
Tickers
AMGN
BMY
GILD
MRK
Tags
General
Benzinga
MRK
From
Benzinga
7 Members Of Congress Failed To Disclose Stock Transactions: Who Was Named, And What's Next?
September 24, 2021
Tickers
GILD
WKHS
Tags
Kirsten Gillibrand
Benzinga
House of Representatives
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
